Close
Company Search
Become a Member
  • Track your favourite stocks
  • Create & monitor portfolios
  • Daily portfolio value
Sign Up
Quickpicks
Add shares to your
quickpicks to
display them here!

Faron Pharmaceuticals (FARN) Share News

234567891011

Faron Pharmaceuticals Knows Of No Reason For 43% Share Price Jump

2nd May 2019 17:30

LONDON (Alliance News) - Faron Pharmaceuticals Ltd on Thursday said it is unable to explain the recent movement in its share price.Faron noted Thursday's 43% share price rise, and said Read More

UK Earnings, Trading Statements Calendar - Next 7 Days

30th Apr 2019 16:02

Wednesday 1 May J SainsburyFull Year ResultsConnect GroupHalf Year GroupQ1 Stock Read More

Faron Gets Results Of Traumakine Study From Japanese Licensing Partner

29th Apr 2019 15:46

LONDON (Alliance News) - Faron Pharmaceuticals Oy on Monday said its Japanese licensing partner Maruishi Pharmaceutical Co Ltd has provided clinical trial results on its phase three Traumakine for Read More

Faron Pharmaceuticals To Focus On Colorectal Cancer In Clevegen Trial

11th Apr 2019 12:13

LONDON (Alliance News) - Faron Pharmaceuticals Oy is to target colorectal cancer in its upcoming test programme for Clevegen, it said Thursday.The testing of Clevegen on patients with will Read More

UPDATE: Faron Pharmaceuticals Raises EUR3.1 Million In Fundraise (ALLISS)

26th Mar 2019 15:52

LONDON (Alliance News) - Finland's Faron Pharmaceuticals Oy on Tuesday afternoon said it has raised EUR3.1 million pursuant to a placing announced earlier in the day.The company issued Read More

Faron Pharmaceuticals Optimistic For Traumakine As It Plans Fundraise (ALLISS)

26th Mar 2019 12:05

LONDON (Alliance News) - Finland's Faron Pharmaceuticals Oy on Tuesday said it expects further disappointing results from Traumakine, as it plans a share placing.Faron is currently for Read More

Faron "Very Encouraged" By Early Clevegen Trials In Cancer Patients

21st Feb 2019 12:17

LONDON (Alliance News) - Faron Pharmaceuticals Ltd on Thursday said early results from a trial of its Clevegen cancer drug are encouraging.Shares in Faron were up 10% at 64.00 pence on said Read More

Faron Pharmaceuticals Encouraged By Clever-1 Antibody Study Result

13th Feb 2019 12:20

LONDON (Alliance News) - Faron Pharmaceuticals Ltd on Wednesday said new data supports the use of Clever-1 antibodies in re-activating an immune response to tumours.Shares in Faron were up Read More

WINNERS & LOSERS SUMMARY: Ashtead Falls On US Economic Slowdown Worry

5th Dec 2018 11:19

LONDON (Alliance News) - The following stocks are the leading risers and fallers within the main London indices on Wednesday.----------FTSE 100 - up 2.7%. Japan's Takeda Pharmaceutical Read More

Faron Pharmaceuticals Finds "Optimal" Patient Group For Traumakine

5th Dec 2018 09:09

LONDON (Alliance News) - Faron Pharmaceuticals Ltd shares jumped on Wednesday as the company said it identified an "optimal" subgroup of patients, with a certain genetic mutation, to be Read More

WINNERS & LOSERS SUMMARY: McColl's Retail Plunges After Profit Warning

3rd Dec 2018 10:50

LONDON (Alliance News) - The following stocks are the leading risers and fallers within the main London indices on Monday.----------FTSE 100 - up 8.9%, Evraz, up 7.8%, up Read More

DIRECTOR DEALINGS: Faron Divisional Chief Medical Officer Buys Shares

6th Nov 2018 16:29

LONDON (Alliance News) - Faron Pharmaceuticals Oy on Tuesday said VP Drug Development Chief Medical Officer Matti Karvonen acquired shares in the biopharmaceutical company.In a transaction Read More

Faron Reports Corticosteroids Interference In Traumakine Trial

22nd Oct 2018 15:32

LONDON (Alliance News) - Faron Pharmaceuticals Ltd said Monday that it has found evidence suggesting that corticosteroids used in parallel to its Traumakine treatment had a significant effect on a Read More

Faron Pharmaceuticals Submits Clinical Trial Application For Clevegen

17th Sep 2018 10:37

LONDON (Alliance News) - Faron Pharmaceuticals Oy said Monday it has filed a clinical trial application for its cancer immunotherapy drug Clevegen.Clevegen, an anti-Clever-1 antibody, the a Read More

WINNERS & LOSERS SUMMARY: Retailers Hit As John Lewis Profit Collapses

13th Sep 2018 10:49

LONDON (Alliance News) - The following stocks are the leading risers and fallers within the main London indices on Thursday.----------FTSE 100 - WINNERS----------Royal Bank a Read More

Faron Pharmaceuticals Falls As Interim Loss Widens On Research Costs

13th Sep 2018 10:30

LONDON (Alliance News) - Shares in Faron Pharmaceuticals Ltd dropped on Thursday after the company said its loss for the first half of its financial year increased on higher research were trading Read More

Faron Pharmaceuticals Says New Clever-1 Data Shows B Cell Response

12th Sep 2018 13:48

LONDON (Alliance News) - Faron Pharmaceuticals Ltd said Wednesday that new data from its cell surface receptor Clever-1 showed B cell response control and humoral antibody production.The by Read More

UK Earnings, Trading Statements Calendar - Next 7 Days

6th Sep 2018 16:01

Friday 7 September Secure Income REITHalf Year Results Ashmore GroupFull Year Year Read More

DIRECTOR DEALINGS: Faron Pharmaceuticals Directors Buy Shares

21st Jun 2018 16:31

LONDON (Alliance News) - Faron Pharmaceuticals Oy said on Thursday several directors purchased shares over the course of three days from Tuesday to Thursday.On Tuesday, Non-Executive Matti Read More

Faron Pharmaceutics Reports Inconsistent Traumakine Biomarker Results

14th Jun 2018 11:30

LONDON (Alliance News) - Faron Pharmaceuticals Oy on Thursday said preliminary biomarker data from its Traumakine phase III trial has produced inconsistent results.Faron is testing in a III Read More

234567891011
FTSE 100 Latest
Value9,491.25
Change63.52